KRAS and colorectal carcinoma: The majority of CRC patients carried mutations in two genes of TP53/APC/KRAS, mutant allele frequencies of which displayed a significant linear correlation, confirming that mutations in these genes regularly co‐occur as clonal events in the evolution of CRC.